VANCOUVER, BC / ACCESSWIRE / December 2, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC ...

It's the diabetes turned 'weight loss' drug that's gone viral in just a few short years. Ozempic has been steeped in ...

Several obesity experts said perhaps 20% of patients — as many as 1 in 5 — may not respond well to the medications.

Some of what RFK Jr. says about obesity prevention isn't new. But after having coined the catchy MAHA acronym, it’s likely ...

Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.

For employers wanting to dip a toe into the GLP-1 medications pool, utilization management is recommended to control costs.

The emergence and development of glucagon-like Peptide-1 agonists (GLP-1s) is the primary trend of interest in the ...

For some, the issue with GLP-1 drugs like Ozempic and Mounjaro isn't getting access to these game-changing medications, but ...

The Biden Administration released plans for a new rule that would require Medicare and Medicaid to cover anti-obesity ...

Whether millions gain access to breakthrough anti-obesity treatments may depend on Kennedy, Mehmet Oz and other key players ...

UPMC cites more people seeking medical care and rising pharmacy costs as reasons for its $371 million operating loss for the first nine months of the year, according to a financial and operating ...

November is Diabetic Eye Disease Awareness Month. Diabetes is the leading cause of preventable blindness in the US. Here is a ...